Used primarily in pharmaceutical research as a kinase inhibitor, particularly targeting cyclin-dependent kinases (CDKs). It serves as a key intermediate in the development of anticancer agents due to its ability to interfere with cell cycle progression. Its structure allows for selective binding to ATP sites in CDK enzymes, making it valuable in studying tumor growth inhibition. Also employed in medicinal chemistry for optimizing drug candidates aimed at treating proliferative diseases.